No Data
No Data
FDA Solicits Public Comments On Use Of Cannabis-derived Products In Veterinary Medicine
DEA Marijuana Rescheduling Hearing Cancelled Following Legal Challenge
Peering Into Tilray Brands's Recent Short Interest
Trump Team Said to Discuss Gradual Tariff Hikes for Leverage, Inflation Control
Earnings Call Summary | Tilray Brands(TLRY.US) Q2 2025 Earnings Conference
Tilray Brands in Charts: Cannabis and Beverage Businesses Show Sequential Growth in FQ2